170 related articles for article (PubMed ID: 38172714)
21. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression.
Zhao F; Li S; Liu J; Wang J; Yang B
Hum Cell; 2022 Jul; 35(4):1234-1247. PubMed ID: 35676608
[TBL] [Abstract][Full Text] [Related]
24. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of circZNF609 targeting miR-153 to regulate the proliferation and apoptosis of diffuse large B-cell lymphoma].
Yang CS; Lou Y; Ke QP; Xu XJ; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):238-245. PubMed ID: 35316873
[No Abstract] [Full Text] [Related]
26. Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation.
Liu S; Xie F; Gan L; Peng T; Xu X; Guo S; Fu W; Wang Y; Ouyang Y; Yang J; Wang X; Zheng Y; Zhang J; Wang H
Genomics; 2020 Nov; 112(6):5343-5355. PubMed ID: 33189780
[TBL] [Abstract][Full Text] [Related]
27. CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis.
Zhang ZX; Zhang WN; Sun YY; Li YH; Xu ZM; Fu WN
Onco Targets Ther; 2018; 11():1323-1331. PubMed ID: 29563811
[TBL] [Abstract][Full Text] [Related]
28. Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development.
Marsman J; O'Neill AC; Kao BR; Rhodes JM; Meier M; Antony J; Mönnich M; Horsfield JA
Biochim Biophys Acta; 2014 Jan; 1839(1):50-61. PubMed ID: 24321385
[TBL] [Abstract][Full Text] [Related]
29. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
30. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
31. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.
Bakshi R; Hassan MQ; Pratap J; Lian JB; Montecino MA; van Wijnen AJ; Stein JL; Imbalzano AN; Stein GS
J Cell Physiol; 2010 Nov; 225(2):569-76. PubMed ID: 20506188
[TBL] [Abstract][Full Text] [Related]
32. NF-κB p65 represses microRNA-124 transcription in diffuse large B-cell lymphoma.
Shim H; Nam J; Kim SW
Genes Genomics; 2020 May; 42(5):543-551. PubMed ID: 32207045
[TBL] [Abstract][Full Text] [Related]
33. RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
35. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.
Seo W; Ikawa T; Kawamoto H; Taniuchi I
J Exp Med; 2012 Jul; 209(7):1255-62. PubMed ID: 22665574
[TBL] [Abstract][Full Text] [Related]
36. YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect.
Hou Y; Zhang Q; Pang W; Hou L; Liang Y; Han X; Luo X; Wang P; Zhang X; Li L; Meng X
Cell Death Differ; 2021 Nov; 28(11):3105-3124. PubMed ID: 34021267
[TBL] [Abstract][Full Text] [Related]
37. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
38. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis.
Bee T; Swiers G; Muroi S; Pozner A; Nottingham W; Santos AC; Li PS; Taniuchi I; de Bruijn MF
Blood; 2010 Apr; 115(15):3042-50. PubMed ID: 20139099
[TBL] [Abstract][Full Text] [Related]
39. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
40. MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX1.
Xue T; Yin G; Yang W; Chen X; Liu C; Yang W; Zhu J
Curr Cancer Drug Targets; 2021; 21(8):702-712. PubMed ID: 33858314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
